HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 1
- 主要终点
- Mean Number of Days Used Primary Drug (NumDU)
研究概览
简要总结
This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.
详细描述
The goal of this study is to compare the effects of brief motivational interviewing with participation in HealthCall to brief motivational interviewing alone on non-injection drug and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use, drinking behaviors and other aspects of health, followed by personalized feedback in a graph after 30 and 60 days of using the smartphone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 and older;
- •During the prior 30 days, > 4 days of non-injection of cocaine, methamphetamine or heroin, one of which is identified by the patient as his/her primary drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion); Completion of medically supervised detoxification if such detoxification is required; HIV Positive ; Able to give informed consent
排除标准
- •Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in the last 6 months Patient has definite plans to leave the greater New York metropolitan area within the study period.
- •Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision impairment that precludes smartphone use.
研究组 & 干预措施
Motivational Interviewing (MI)
Participants will engage in a 30-minute Motivational Interviewing session with the study counselor to discuss participant's drug and alcohol use, its implications for their health, and the possibility of drug and alcohol use reduction. This counseling session is intended to help people reduce their drug and alcohol use if they wish. In the counseling session, participants describe the pros and cons of their drug and alcohol use and whether it might be important to quit using drugs and drinking alcohol. Open discussion of the pros (what they like about drug use and drinking) and cons (what they don't like) can help people think about reducing drug and alcohol use in a more complete way than they might have before. This arm will be compared to the HealthCall+Motivational Interviewing arm.
干预措施: Motivational Interviewing (Behavioral)
HealthCall+Motivational Interviewing
The HealthCall+Motivational Interviewing arm will investigate whether the addition of HealthCall, a smartphone application designed to keep track of the participant's drug and alcohol use and other health-related behaviors through short daily use, will help participants reduce their substance use more than Motivational Interviewing alone. Participants will receive the same 30-minute Motivational Interviewing session as described in the MI arm. After the session, participants will be introduced to HealthCall and will be asked to use the app daily over the next 30 days. Each use lasts 2-3 minutes and can be done anywhere on the phone in the U.S. The purpose of daily HealthCall use is to help participants keep track of their drug and alcohol use.
干预措施: HealthCall+Motivational Interviewing (Behavioral)
结局指标
主要结局
Mean Number of Days Used Primary Drug (NumDU)
时间窗: 60 days
This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Dollar Amount Spent Per Day on Primary Drug (QuantU)
时间窗: 60 days
This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Number of Drinking Days (NumDD)
时间窗: 60 days
This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Number of Drinks Per Day (QuantDD)
时间窗: 60 days
This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
次要结局
未报告次要终点
研究者
Efrat Aharonovich
Research Scientist V
Research Foundation for Mental Hygiene, Inc.
